Show simple item record

Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate

dc.contributor.authorPalacios, Santiago
dc.contributor.authorNeyro, José Luis
dc.contributor.authorFerrer Barriendos, Francisco Javier 
dc.contributor.authorVillero, José
dc.contributor.authorCañada, Enrique
dc.contributor.authorRedondo, Esther
dc.contributor.authorCaloto, María Teresa
dc.contributor.authorNocea, Gonzalo
dc.date.accessioned2013-01-30T09:59:41Z
dc.date.available2013-01-30T09:59:41Z
dc.date.issued2012
dc.identifier.citationMenopause-the Journal of the North American Menopause Society, 19(1), p. 67-74 (2012); doi:10.1097/gme.0b013e3182214f5aspa
dc.identifier.issn1072-3714
dc.identifier.urihttp://hdl.handle.net/10651/6730
dc.description.statementofresponsibilityPalacios, S., Neyro, J.L., Ferrer, J., Villero, J., Cañada, E., Redondo, E., Caloto, M.T., Nocea, G.
dc.format.extentp. 67-74spa
dc.language.isoeng
dc.relation.ispartofMenopause-the Journal of the North American Menopause Societyspa
dc.sourceWOKspa
dc.titleReduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronatespa
dc.typejournal article
dc.identifier.local20120091spa
dc.identifier.doi10.1097/gme.0b013e3182214f5a
dc.relation.publisherversionhttp://dx.doi.org/10.1097/gme.0b013e3182214f5aspa


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record